Table 1 Characteristics of enrolled patients according to MACE
Total (N = 285) | MACE (N = 49) | Non-MACE (N = 236) | P value | |
|---|---|---|---|---|
Age (years) | 56.6 ± 12.3 | 61.2 ± 11.5 | 55.7 ± 12.2 | 0.004 |
Women, n(%) | 129 (45.3) | 24 (49.0) | 105 (44.5) | 0.566 |
BMI (kg/m2) | 24.7 ± 3.6 | 23.9 ± 3.4 | 24.8 ± 3.6 | 0.096 |
Clinical status | ||||
Typical angina, n(%) | 144 (50.5) | 26 (53.1) | 118 (50.0) | 0.821 |
Atypical angina, n(%) | 98 (34.4) | 17 (34.7) | 81 (34.3) | |
Non-anginal chest pain, n(%) | 43 (15.1) | 6 (12.2) | 37 (15.7) | |
Abnormal electrocardiogram, n(%) | 170 (59.6) | 27 (55.1) | 143 (60.6) | 0.476 |
Coronary artery stenosis | ||||
Without detectable stenosis, n(%) | 166 (58.2) | 21 (42.9) | 145 (61.4) | 0.055 |
1% ~ 24%, n(%) | 74 (26.0) | 17 (34.7) | 57 (24.2) | |
25% ~ 49%, n(%) | 45 (15.8) | 11 (22.4) | 34 (14.4) | |
Medical history | ||||
Hypertension, n(%) | 128 (44.9) | 26 (53.1) | 102 (43.2) | 0.208 |
Diabetes, n(%) | 38 (13.3) | 10 (20.4) | 28 (11.9) | 0.109 |
Smoking, n(%) | 103 (36.1) | 17 (34.7) | 86 (36.4) | 0.817 |
Dyslipidemia, n(%) | 17 (6.0) | 4 (8.2) | 13 (5.5) | 0.475 |
Cardiovascular family history, n(%) | 92 (32.3) | 20 (40.8) | 72 (30.5) | 0.160 |
Medications | ||||
Anticoagulant/Antiplatelet, n(%) | 219 (76.8) | 41 (83.7) | 178 (75.4) | 0.213 |
ACEI/ARB, n(%) | 113 (39.6) | 20 (40.8) | 93 (39.4) | 0.854 |
Beta-blocker, n(%) | 123 (43.2) | 19 (38.8) | 104 (44.1) | 0.496 |
CCB, n(%) | 83 (29.1) | 20 (40.8) | 63 (26.7) | 0.048 |
Statin, n(%) | 212 (74.4) | 41 (83.7) | 171 (72.5) | 0.102 |
Laboratory variables | ||||
Hemoglobin (g/L) | 142.4 ± 15.0 | 137.0 ± 16.0 | 143.5 ± 14.6 | 0.006 |
Red blood cell (× 1012/L) | 4.6 ± 0.9 | 4.4 ± 0.5 | 4.7 ± 0.9 | 0.019 |